Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.

The document's conclusion cannot be provided because the document is not readable or understandable.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Individualized homeopathic treatment led to complete hair regrowth in a patient with stress-induced hair loss.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Weight loss can cause temporary hair loss, especially in women and older adults.

Post-COVID-19 patients are at risk for hair loss.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

COVID-19 survivors working in healthcare may experience temporary hair loss.

COVID-19 infection is highly related to increased hair loss, especially in women.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

The oral supplement improved hair loss in patients with telogen effluvium.

Low iron levels are linked to more hair loss in women with chronic hair shedding.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.